2-(2,3-dicarboxycyclopropyl)glycine has been researched along with mrs 1191 in 1 studies
| Studies (2-(2,3-dicarboxycyclopropyl)glycine) | Trials (2-(2,3-dicarboxycyclopropyl)glycine) | Recent Studies (post-2010) (2-(2,3-dicarboxycyclopropyl)glycine) | Studies (mrs 1191) | Trials (mrs 1191) | Recent Studies (post-2010) (mrs 1191) |
|---|---|---|---|---|---|
| 166 | 0 | 27 | 43 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagena, H; Manahan-Vaughan, D | 1 |
1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and mrs 1191
| Article | Year |
|---|---|
Frequency facilitation at mossy fiber-CA3 synapses of freely behaving rats contributes to the induction of persistent LTD via an adenosine-A1 receptor-regulated mechanism.
Topics: Adenosine A1 Receptor Antagonists; Analysis of Variance; Animals; Biophysics; CA3 Region, Hippocampal; Cyclopropanes; Dihydropyridines; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glycine; Long-Term Synaptic Depression; Male; Mossy Fibers, Hippocampal; Rats; Rats, Wistar; Receptor, Adenosine A1; Statistics as Topic; Time Factors; Valine; Wakefulness; Xanthines; Xylenes | 2010 |